Table S5 from RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types

<p>Table S5. Gene copy number for key signaling proteins from the NCI PDMR patient-derived cancer cell lines.</p>

Authors

Nathan P. Coussens (ORCID: https://orcid.org/0000-0002-3896-7909)
Beverly A. Teicher (ORCID: https://orcid.org/0000-0003-1535-7304)
James H. Doroshow (ORCID: https://orcid.org/0000-0002-4463-1790)
Thomas E. Silvers (ORCID: https://orcid.org/0009-0003-7907-1177)
Thomas Steven Dexheimer (ORCID: https://orcid.org/0000-0002-6444-3121)
Samantha B. Kemp (ORCID: https://orcid.org/0000-0002-1505-4015)
Zahra Davoudi (ORCID: https://orcid.org/0000-0003-0828-5971)
Melinda G. Hollingshead (ORCID: https://orcid.org/0000-0002-1207-1397)
Naoko Takebe (ORCID: https://orcid.org/0000-0002-5790-4954)
Joel Morris (ORCID: https://orcid.org/0009-0008-6156-1393)
Poorva Juneja
Raymond G. Fox